Bicalutamide
(R)-Bicalutamide(R)-bicalutamide(S)-Bicalutamide(S)-bicalutamideATC code L02BB03ATCvet code QL02BB03BRN-5364666BRN5364666BRN 5364666BicalutamidBicalutamidaBicalutamidiBicalutamidumBikalutamidBikalutamideBikalutamidiC18H14F4N2O4SCalutideCasadexCasodexCosudexICI-176,334ICI-176334ICI176,334ICI176334ICI 176,334ICI 176334KalumidKasadexKasedexKasodexR-BicalutamideR-bicalutamideS-BicalutamideS-bicalutamideZolaCosZolaCos CPZolacosZolacos CP
Wikipage redirect
primaryTopic
Bicalutamide
has abstract
Bicalutamida é um fármaco anti ...... ncer de próstata e hirsutismo.
@pt
Bicalutamide (brand name Casod ...... eded in a basic health system.
@en
Bicalutamide (commercializzato ...... fasi iniziali della malattia.
@it
Bicalutamide is een geneesmidd ...... sodex en als generiek product.
@nl
ATC prefix
ATC suffix
CAS number
90357-06-5
CAS supplemental
113299-40-4 ((R)-isomer)
DrugBank
FDA UNII code
A0Z3NAU9DP
IUPAC name
(RS)-N-[4-cyano-3-(trifluorome ...... -2-hydroxy-2-methylpropanamide
@en
PubChem
thumbnail
Link from a Wikipage to an external page
Wikipage page ID
Wikipage revision ID
744,995,456
bioavailability
Well-absorbed; absolute bioavailability unknown
ChemSpiderID
chirality
date
elimination half-life
-864000.0
excretion
IUPHAR ligand
legal status
licence US
MedlinePlus
melting high
melting point
metabolism
• Glucuronidation
• Hydroxylation
metabolites
• Bicalutamide glucuronide
• Hydroxybicalutamide
molecular weight
4.30373e+2
PDB ligand
pronounce
protein bound
-Isomer: 99.6%
Racemate: 96.1%
routes of administration
smiles
O=CCCSc2ccccc2
solubility
StdInChIKey
LKJPYSCBVHEWIU-UHFFFAOYSA-N